1. Home
  2. FBIO vs XPL Comparison

FBIO vs XPL Comparison

Compare FBIO & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • XPL
  • Stock Information
  • Founded
  • FBIO 2006
  • XPL 1984
  • Country
  • FBIO United States
  • XPL United States
  • Employees
  • FBIO N/A
  • XPL N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • XPL Precious Metals
  • Sector
  • FBIO Health Care
  • XPL Basic Materials
  • Exchange
  • FBIO Nasdaq
  • XPL Nasdaq
  • Market Cap
  • FBIO 49.1M
  • XPL 46.5M
  • IPO Year
  • FBIO N/A
  • XPL N/A
  • Fundamental
  • Price
  • FBIO $1.69
  • XPL $0.62
  • Analyst Decision
  • FBIO Strong Buy
  • XPL Strong Buy
  • Analyst Count
  • FBIO 3
  • XPL 2
  • Target Price
  • FBIO $21.00
  • XPL $1.60
  • AVG Volume (30 Days)
  • FBIO 144.5K
  • XPL 73.6K
  • Earning Date
  • FBIO 05-19-2025
  • XPL 05-02-2025
  • Dividend Yield
  • FBIO N/A
  • XPL N/A
  • EPS Growth
  • FBIO N/A
  • XPL N/A
  • EPS
  • FBIO N/A
  • XPL N/A
  • Revenue
  • FBIO $57,675,000.00
  • XPL N/A
  • Revenue This Year
  • FBIO $63.20
  • XPL N/A
  • Revenue Next Year
  • FBIO $66.70
  • XPL N/A
  • P/E Ratio
  • FBIO N/A
  • XPL N/A
  • Revenue Growth
  • FBIO N/A
  • XPL N/A
  • 52 Week Low
  • FBIO $1.33
  • XPL $0.54
  • 52 Week High
  • FBIO $2.89
  • XPL $0.98
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 52.97
  • XPL 48.26
  • Support Level
  • FBIO $1.67
  • XPL $0.59
  • Resistance Level
  • FBIO $1.84
  • XPL $0.66
  • Average True Range (ATR)
  • FBIO 0.09
  • XPL 0.02
  • MACD
  • FBIO 0.01
  • XPL -0.00
  • Stochastic Oscillator
  • FBIO 58.54
  • XPL 41.71

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About XPL Solitario Resources Corp.

Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.

Share on Social Networks: